TAK-071 Scopolamine-Induced Cognitive Impairment Study

Clinical trial NCT02918266 · TERMINATED

Trial details

NCT number: NCT02918266
Sponsor: Takeda
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2016-11-21
Primary completion: 2017-08-02
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.